Sequence variation of NS3 and NS4A in hepatitis C virus (HCV) replicons following exposure to ITMN-191 concentrations likely to encompass those achieved in human liver following clinical dosing
AJV Thompson, JG McHutchison
Journal of Viral Hepatitis | WILEY | Published : 2009
We are grateful to Dr Scott Bowden of the Victorian Infectious Diseases Reference Laboratory, and Dr Nathan Niceley of the Duke Human Vaccine Institute, Duke University, for advice provided during the preparation of this manuscript. This work has been supported by the Duke Fellowship, provided by the Gastroenterological Society of Australia, and the IMS Travelling Scholarship, provided by the Royal Australasian College of Physicians.